# Kyntra Bio, Inc.: Form 8-K, filed Oct 1, 2026

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2026-10-01
- Accepted by EDGAR: Oct 1, 2026, 11:30 ET
- Period: 2026-09-30
- Accession: 0001193125-26-409819
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000119312526409819/kynb-20260930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000119312526409819/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000119312526409819/kynb-20260930.htm

Filed Oct 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-409819. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.